Literature DB >> 18779601

Myeloma therapy: 25 years forward--immune modulation then and now.

Brian G M Durie1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18779601     DOI： 10.1200/JCO.2008.18.0109

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  1 in total

1.  A phase I multidose study of dacetuzumab (SGN-40; humanized anti-CD40 monoclonal antibody) in patients with multiple myeloma.

Authors:  Mohamad Hussein; James R Berenson; Ruben Niesvizky; Nikhil Munshi; Jeffrey Matous; Ronald Sobecks; Kate Harrop; Jonathan G Drachman; Nancy Whiting
Journal:  Haematologica       Date:  2010-02-04       Impact factor: 9.941
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.